CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home›
Investors›
Critical Path Ventures›
News
Critical Path Ventures

Critical Path Ventures

Operating Status: Operating

Critical Path Ventures is a Paris-based deeptech investment firm backing researcher-founded startups from seed stage.

Location
Paris, FR
Founded
2022
Firm
Compare
Portfolio
Employees
News
Library

Latest News About Critical Path Ventures

Prophesee lève 20 millions et lance Mantara : un système de détection de drones

J'aime les Startups

Prophesee lève 20 millions et lance Mantara : un système de détection de drones

Prophesee raised 20 million euros led by French fund Critical Path Ventures and unveiled Mantara, an integrated event-based drone detection...

Jun 15, 2026

Sonomind stimule son capital en serie A

CFNEWS

Sonomind stimule son capital en serie A

Sonomind closed a Series A for its brain-stimulation device with Critical Path Ventures investing alongside Bpifrance to launch clinical...

May 12, 2026

Alkion BioInnovations lève 4.4 millions d'euros pour industrialiser la production durable d'adjuvants vaccinaux QS-21

Gazette du Laboratoire

Alkion BioInnovations lève 4.4 millions d'euros pour industrialiser la production durable d'adjuvants vaccinaux QS-21

Alkion BioInnovations raised 4.4 million euros led by GO Capital and Critical Path Ventures to scale GMP production of the QS-21 vaccine...

Nov 26, 2025

RDS Raises 14 Million EUR to Develop its Remote Patient Monitoring Tool

Medical Product Outsourcing

RDS Raises 14 Million EUR to Develop its Remote Patient Monitoring Tool

RDS secured 14 million euros in Series A with first-time support from Critical Path Ventures, whose Nicolas Foessel joined the RDS board...

Oct 30, 2025

RDS lève 14 millions d'euros pour industrialiser son patch connecté de suivi des patients à distance

Bpifrance

RDS lève 14 millions d'euros pour industrialiser son patch connecté de suivi des patients à distance

RDS announced a 14 million euro Series A led by Bpifrance SPI with new investor Critical Path Ventures, whose representative Nicolas...

Sep 29, 2025

RDS secures 14M EUR to scale MultiSense remote patient monitoring patch

Tech Funding News

RDS secures 14M EUR to scale MultiSense remote patient monitoring patch

RDS raised 14 million euros in Series A led by Bpifrance SPI with Critical Path Ventures participating, and welcomed Nicolas Foessel of...

Sep 29, 2025